Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) EBT Margin (2018 - 2025)

AVITA Medical filings provide 8 years of EBT Margin readings, the most recent being 12.65% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 5138.0% to 12.65% in Q4 2025 year-over-year; TTM through Dec 2025 was 33.27%, a 6365.0% increase, with the full-year FY2025 number at 68.53%, up 2816.0% from a year prior.
  • EBT Margin hit 12.65% in Q4 2025 for AVITA Medical, up from 77.2% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 265.15% in Q4 2023 to a low of 167.76% in Q1 2024.
  • Median EBT Margin over the past 5 years was 71.56% (2021), compared with a mean of 58.47%.
  • Biggest five-year swings in EBT Margin: skyrocketed 32294bps in 2023 and later crashed -32918bps in 2024.
  • AVITA Medical's EBT Margin stood at 84.64% in 2021, then soared by 32bps to 57.79% in 2022, then soared by 559bps to 265.15% in 2023, then crashed by -124bps to 64.03% in 2024, then surged by 80bps to 12.65% in 2025.
  • The last three reported values for EBT Margin were 12.65% (Q4 2025), 77.2% (Q3 2025), and 53.84% (Q2 2025) per Business Quant data.